Vanda Pharma
VNDA----
Vanda Pharma (VNDA)
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs world...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Vanda Pharma Analyst Rating
View MoreForecast & Rating
Jul 22, 2026Price forecast
$14.13172.68%
Forecast & RatingBuy
4analysts
- Strong buy75.00%
- Buy0.00%
- Hold25.00%
- Sell0.00%
- Strong sell0.00%
News
- Fiercepharma · Jul 16 at 01:13 PM
Vanda shifts into high gear with Schumacher IndyCar sponsorship
- StockTitan · Jul 15 at 07:30 AM
NEREUS™ Powers Forward: Sponsors No. 47 IndyCar Entry, Celebrating 47 Years Since Last New U.S. Motion Sickness Treatment | VNDA Stock News
- StockTitan · Jul 10 at 07:30 AM
Vanda Pharmaceuticals Announces Participation in the B. Riley Securities 2026 Mind, Muscle & Vision Summit | VNDA Stock News
- Pharmaceutical Technology · Jul 8 at 04:15 AM
FDA grants rare paediatric designation to Vanda’s CMT2S therapy
- StockTitan · Jul 7 at 07:30 AM
Vanda Pharmaceuticals Announces FDA Rare Pediatric Disease Designation for Investigational Therapy for Charcot-Marie-Tooth Disease Type 2S | VNDA Stock News
- Market Beat · May 30 at 01:10 AM
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Given Consensus Recommendation of "Moderate Buy" by Analysts
